Skip to main content
Content for healthcare professionals only
  • Radcliffe Group
  • Cardiology
  • Vascular
  • Medical Education
Radcliffe Cardiology Logo
Register for FREE Log In
View all Platforms Cardiology
Topics Content Type Videos Articles Journals Broadcasts Education Podcasts Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events
Radcliffe Platforms
Radcliffe Group Cardiology Vascular Medical Education
  • Twitter Logo
  • Facebook Logo
  • Youtube Logo
  • Linkedin Logo
  • Instagram Logo
Register for FREE Log In
  • Content for healthcare professionals only
  • Twitter Logo
  • Facebook Logo
  • Youtube Logo
  • Linkedin Logo
  • Instagram Logo

Topics

Featured
Advancement in Heart FailureAmyloidosisCardiomyopathyCardio-oncologyDiabetesHypertension ManagementNonalcoholic Steatohepatitis (NASH)ObesityPulmonary EmbolismStroke Prevention in Atrial FibrillationSudden Cardiac Death
AnticoagulationCOVID-19CV Disease in Special PopulationsDemographicDigital HealthElectrophysiology & ArrhythmiaHeart FailureHeterogeneous PopulationsImaging & DiagnosticsInterventionMI / ACSPericardium DisordersPrevention & Chronic ConditionsStandards & GuidelinesVascular Disease & Surgery

Content Type

Videos Articles Journals Broadcasts Education Podcasts

Journals

AER CFR ECR ICR3 JAPSC USC

Faculty

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All
Juan Carlos KaskiPeter O'KaneAnkur KalraAngelo AuricchioHarriette Van SpallAndrew CoatsMirvat AlasnagArjun GhoshDemos KatritsisNicolas Van MieghemJoost DaemenCarolyn Lam

Events

Upcoming Events Radcliffe Events All Events

Breadcrumb

  • Home /
  • News Index

Latest News

Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin Signaling Inhibitor to Treat Adults with Pulmonary Arterial Hypertension (PAH)
Written by: Merck
Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin…
02 October 2023
Written by: Radcliffe Cardiology
Radcliffe Cardiology partners with KDIGO for creation of independent medical education programmes
08 September 2023
Alvimedica launches the new Alvision™ KAPLAN curves radial portfolio for diagnostic procedures
Written by: Alvimedica
Alvimedica launches the new Alvision™ KAPLAN curves radial portfolio for diagnostic procedures
05 July 2023
DELIVER Trial: Prespecified Analysis Demonstrates Dapagliflozin Benefits Across Subgroups
Written by: Radcliffe Cardiology
DELIVER Trial: Prespecified Analysis Demonstrates Dapagliflozin Benefits Across Subgroups
21 June 2023
Latest AI technology improves echocardiogram reproducibility and repeatability
Written by: EchoNous
Latest AI technology improves echocardiogram reproducibility and repeatability
19 June 2023
IC-OS Partnership
Written by: Radcliffe Cardiology
Radcliffe Cardiology partners with the International Cardio-Oncology Society for weekly educational…
25 May 2023
Comparative Evaluation of Torsemide and Furosemide in Heart Failure: Impact on Patient-Reported Outcomes and Quality of Life - Findings from the TRANSFORM-HF Trial
Written by: Radcliffe Cardiology
Comparative Evaluation of Torsemide and Furosemide in Heart Failure: Impact on Patient-Reported Outcomes and…
25 May 2023
NUDGE-FLU: What Interventions May Increase Vaccination Rates in Heart Failure Patients
Written by: Radcliffe Cardiology
NUDGE-FLU: What Interventions May Increase Vaccination Rates in Heart Failure Patients
22 May 2023
The Association Between Sodium Intake and Coronary and Carotid Atherosclerosis in the General Swedish Population
Written by: Radcliffe Cardiology, Mirjam Boros
The Association Between Sodium Intake and Coronary and Carotid Atherosclerosis in the General Swedish…
20 April 2023
Increase in CCTA use reduces hospitalizations and death rates
Written by: About the Society of Cardiovascular Computed Tomography
Increase in CCTA use reduces hospitalizations and death rates
19 January 2023
  • Load More

External news

Written by: Cardiovascular Business
FDA clears AI model for detecting signs of heart failure in ECGs
03 October 2023
Written by: Cardiovascular Business
Report: Private equity firm exploring deal worth more than $7B to acquire 2 Medtronic businesses
03 October 2023
Written by: Cardiovascular Business
Cordis finalizes deal to acquire MedAlliance for up to $1.1B
03 October 2023
Written by: American College of Cardiology
Total-Body PET in Cardiovascular Research: Key Points
03 October 2023
Written by: American College of Cardiology
Novel Devices for Acute Cardiorenal Syndrome: Key Points
03 October 2023
Written by: American College of Cardiology
Fluoroquinolone and Aortic Aneurysm or Dissection
03 October 2023
Written by: Medscape
FDA Greenlights Balfaxar for Warfarin Reversal
03 October 2023
Written by: Medscape
Longer Edoxaban May Benefit Cancer Patients With Distal DVT
03 October 2023
Written by: Medscape
PET Scan at Diagnosis May Help Predict Aneurysm Risk in GCA
02 October 2023
Written by: Cardiac Vascular News
Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study
02 October 2023
  • Load More

Footer Menu 1

  • About Us
  • Our Team
  • Privacy
  • Terms & Conditions
  • Contact Us

Footer Menu 2

  • Authors A-Z
  • Image Gallery
  • Media Partners
  • Industry Partners
  • Services
  • Promotional Opportunities
  • Arrhythmia Academy
  • Education by Breas

Quick Links 1

  • Advancements in Heart Failure
  • Amyloidosis
  • Cardiomyopathy
  • Cardio-oncology
  • Diabetes
  • Hypertension Management

Quick Links 2

  • NASH
  • Obesity
  • Pulmonary Embolism
  • Stroke Prevention in Atrial Fibrillation
  • Sudden Cardiac Death
  • Twitter Logo
  • Facebook Logo
  • Youtube Logo
  • Linkedin Logo
  • Instagram Logo
Register for FREE
Radcliffe Cardiology Logo

Copyright® 2023 Radcliffe Medical Media. All rights reserved.

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media.

Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.